SCHEMBL8959176

SCHEMBL8959176

Cc1ccc2cc(N)[nH]c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.54
DAO P14920 1/20 0.52
DDO Q99489 1/20 0.52
MAPT P10636 2/20 0.49
RXFP1 Q9HBX9 1/20 0.49
CA12 O43570 1/20 0.47
CA9 Q16790 1/20 0.47
EHMT2 Q96KQ7 1/20 0.47
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2B Q13224 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
ALDH1A1 P00352 4/20 0.45
ITK Q08881 3/20 0.45
KDM4E B2RXH2 3/20 0.45
HSD17B10 Q99714 1/20 0.45
CYP1A2 P05177 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL130537 0.83 LOXL2 (0.58) AOC3DAOMAPTCA12CA9
SCHEMBL890079 0.77 DAO (0.55) DAODDOMAPTRXFP1CA12
SCHEMBL30807019 0.77 DAO (0.55) DAODDOMAPTRXFP1CA12
SCHEMBL27512966 0.74 CA2 (0.55) AOC3EHMT2CYP1A2FLT3GAA
SCHEMBL22310730 0.74 AOC3 (0.54) AOC3MAPTEHMT2ALDH1A1ITK
SCHEMBL28238795 0.74 AOC3 (0.54) AOC3DAODDOEHMT2ALDH1A1
SCHEMBL13655518 0.74 DAO (0.52) DAODDOMAPTRXFP1CA12
SCHEMBL8288035 0.74 DAO (0.52) DAODDOMAPTRXFP1CA12
SCHEMBL28239799 0.74 AOC3 (0.54) AOC3DAOEHMT2GRIN2DGRIN3B
SCHEMBL27957027 0.74 DAO (0.52) DAODDOMAPTRXFP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0424261-B1 Dyeing composition containing oxidation dyes precursors and aminoindole derivatives as coupling agent OREAL (FR) 1996-01-03 EP claimed
EP-0424261-A1 Dyeing composition containing oxidation dyes precursors and aminoindole derivatives as coupling agent L'OREAL (FR) 1991-04-24 EP claimed
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 US disclosed
EP-2588451-B1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INT (DE) 2015-12-30 EP disclosed
US-8637542-B2 Kinase inhibitors and methods of use INTELLIKINE, INC. (US) 2014-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF NSD3, PML, NSD1 AOC3 4361/4885DAO 878/4885DDO 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.